Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.

Saved in:
Bibliographic Details
Title: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.
Authors: Lenferink AEG; Medical Devices Research Centre, National Research Council Canada, Montréal, QC, Canada., Zwaagstra JC; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Baardsnes J; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Delafosse L; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Parat M; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Iqbal U; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Lessard E; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada., Haqqani AS; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada., Jezierski A; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.; Department of Medicine, Goodman Cancer Institute, McGill University, Montréal, QC, Canada., Abu-Thuraia A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Tabariès S; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Siegel PM; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada., Sulea T; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, QC, Canada.
Source: Frontiers in oncology [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1648779. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41220943
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lenferink+AEG%22">Lenferink AEG</searchLink>; Medical Devices Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Zwaagstra+JC%22">Zwaagstra JC</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Baardsnes+J%22">Baardsnes J</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Delafosse+L%22">Delafosse L</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Parat+M%22">Parat M</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Iqbal+U%22">Iqbal U</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Lessard+E%22">Lessard E</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Haqqani+AS%22">Haqqani AS</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Jezierski+A%22">Jezierski A</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.; Department of Medicine, Goodman Cancer Institute, McGill University, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Abu-Thuraia+A%22">Abu-Thuraia A</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Tabariès+S%22">Tabariès S</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Siegel+PM%22">Siegel PM</searchLink>; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Sulea+T%22">Sulea T</searchLink>; Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.; Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, QC, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Oct 27; Vol. 15, pp. 1648779. <i>Date of Electronic Publication: </i>2025 Oct 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41220943
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1648779
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1648779
    Titles:
      – TitleFull: Engineered multifunctional transforming growth factor-β type II receptor ectodomain fusions for oncology applications.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lenferink AEG
      – PersonEntity:
          Name:
            NameFull: Zwaagstra JC
      – PersonEntity:
          Name:
            NameFull: Baardsnes J
      – PersonEntity:
          Name:
            NameFull: Delafosse L
      – PersonEntity:
          Name:
            NameFull: Parat M
      – PersonEntity:
          Name:
            NameFull: Iqbal U
      – PersonEntity:
          Name:
            NameFull: Lessard E
      – PersonEntity:
          Name:
            NameFull: Haqqani AS
      – PersonEntity:
          Name:
            NameFull: Jezierski A
      – PersonEntity:
          Name:
            NameFull: Abu-Thuraia A
      – PersonEntity:
          Name:
            NameFull: Tabariès S
      – PersonEntity:
          Name:
            NameFull: Siegel PM
      – PersonEntity:
          Name:
            NameFull: Sulea T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 10
              Text: 2025 Oct 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1